OCT 17, 2016 7:40 PM PDT

Gene Therapy to Prevent Heart Failure

WRITTEN BY: Kara Marker
For reasons not completely understood by scientists, our own heart muscle cells, called cardiomyocytes, secrete a protein that ultimately leads to heart failure. In a new study from Kumamoto University, researchers find out why and how to stop it.
Angiopoietin-like protein 2 (ANGPTL2) reduces the contractile force of the heart by both decreasing the production of cellular energy and the ability of calcium concentration to be regulated within the cardiomyocytes. Excessive secretion of these proteins occurs when aged cells and/or cells under stress due to high blood pressure, the researchers found in the recent Nature Communications study, which investigated the potential of developing gene therapy to treat ANGPTL-2-related heart failure.

"We genetically engineered a non-pathogenic virus which was designed to infect cardiac muscle cells and reproduce a special RNA molecule that inhibit the production of the ANGPTL2 protein," said Kumamoto University Professor Yuichi Oike. “Among knockout mice that could not produce [ANGPTL2], the development of heart failure was suppressed in a manner similar to moderate exercise.”

Oike’s study suggests gene therapy to inhibit production of ANGPTL2, which could provide beneficial therapeutic effects for people at risk of heart failure. Oike showed that these beneficial effects are possible in both a heart failure mouse model and in human cardiomyocytes differentiated from induced pluripotent stem cells (iPSCs), due to a correction in calcium concentration regulation and energy production when ANGPLT2 production was suppressed.

Excessive secretion of ANGPTL2 by cells experiencing stress causes chronic inflammation, which leads to heart failure but also other lifestyle-related diseases like atherosclerosis, obesity, diabetes, and cancer. The protein causes the development of these diseases because of its debilitating effect on the contractile force of the heart, but the good news is that moderate exercise can reduce its excessive production by cardiomyocytes, which is one of the reasons regular physical activity is famous for maintaining a healthy heart.

Individuals with severe heart failure are only 50 to 60 percent likely to survive five years, so an effective gene therapy could give thousands of Americans with heart failure a much better prognosis. 
 


Sources: Kumamoto University, American Heart Association
About the Author
I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JAN 20, 2022
Cardiology
New Imaging Study Shows How COVID Damages the Heart
JAN 20, 2022
New Imaging Study Shows How COVID Damages the Heart
New research has shown changes to heart muscle tissue in patients who died of COVID-19.
MAR 21, 2022
Cardiology
How Does Wartime Stress Impact the Heart?
MAR 21, 2022
How Does Wartime Stress Impact the Heart?
In the United States, heart disease is the leading cause of death. However, the impact of heart disease is felt around t ...
APR 07, 2022
Cardiology
Resistance Exercise Leads to Better Sleep
APR 07, 2022
Resistance Exercise Leads to Better Sleep
A new study suggests that resistance exercise is best for getting a good night's rest.
APR 06, 2022
Cardiology
Are Leadless Pacemakers the Future?
APR 06, 2022
Are Leadless Pacemakers the Future?
The human heart rate is under the influence of various hormonal and neural control mechanisms. Normally, conduction of a ...
JUN 16, 2022
Cardiology
Height May Be a Risk Factor for Several Conditions
JUN 16, 2022
Height May Be a Risk Factor for Several Conditions
A new study has linked height to a lower risk of coronary heart disease and a higher risk of some circulatory disorders.
JUN 19, 2022
Drug Discovery & Development
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
JUN 19, 2022
Math Model Predicts Anti-inflammatory Drug Efficacy Post-heart Attack
Researchers created a mathematical model that can predict drug combinations that may one day help treat heart attacks. T ...
Loading Comments...